Skip to main content

Table 1 Cases of breast squamous cell carcinoma with pathological complete response

From: A case of squamous cell carcinoma of the breast achieved a pathological complete response after dose-dense AC + dose-dense PTX

Case

Authors

Age

Pathological features

NAC regimens

1

Chen et al. [3]

48

ER(−), PR(−), HER2(−)Ki-67(60%)

TC 4 cycles

2

Alan et al. [4]

72

ER(≤ 1%), PR(−), HER2(−), Ki-67 (N/A)

wPTX + EC

3

Noro et al. [5]

40

ER(−), PR(−), HER2(−)Ki-67(N/A)

AC 1cycle + wPTX 12cycles

4

Usui et al. [6]

48

ER(−), PR(−), HER2(+)Ki-67(N/A)

Dose-dense AC 4cycles, HP + DTX 4cycles

5

Sakuma et al. [7]

57

ER(−), PR(−), HER2(−)Ki-67(N/A)

EC 4cycles DTX 4cycles

6

Dejager et al. [8]

61

ER(−), PR(−), HER2(+)Ki-67(N/A)

CDDP + 5-FU

7

Present case

56

ER(−), PR(−), HER2(−)Ki-67(90%)

Dose-dense AC 4cycles, Dose-dense PTX 4cycles

  1. ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; N/A, not applicable; TC, docetaxel and carboplatin; wPTX, weekly paclitaxel; EC, epirubicin and cyclophosphamide; AC, doxorubicin and cyclophosphamide; HP, trastuzumab and pertuzumab; DTX, docetaxel; CDDP + 5FU, cisplatinum + 5-fluorouracil